Skip to main content

Array Biopharma Shares Up 29.4% Since SmarTrend's Buy Recommendation (ARRY)

SmarTrend identified an Uptrend for Array Biopharma (NASDAQ:ARRY) on December 22nd, 2017 at $11.94. In approximately 3 months, Array Biopharma has returned 29.37% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.